Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome

被引：72
作者：
Zwiers, Carolien [1 ]
van Kamp, Inge [1 ]
Oepkes, Dick [1 ]
Lopriore, Enrico [2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Obstet, POB 9600, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands
来源：
EXPERT REVIEW OF HEMATOLOGY | 2017年 / 10卷 / 04期
关键词：
Fetal anemia; fetal therapy; hemolytic disease of the fetus and newborn; intrauterine blood transfusion; intravenous immunoglobulin; therapeutic plasma exchange and red cell alloimmunization in pregnancy; RED-CELL ALLOIMMUNIZATION; DOSE INTRAVENOUS IMMUNOGLOBULIN; SEVERE ERYTHROBLASTOSIS-FETALIS; PROCEDURE-RELATED COMPLICATIONS; SEVERE RHESUS ISOIMMUNIZATION; RH D-ALLOIMMUNIZATION; ANTI-D CONCENTRATIONS; INTRAVASCULAR TRANSFUSIONS; GAMMA-GLOBULIN; EXCHANGE-TRANSFUSION;
D O I：
10.1080/17474086.2017.1305265
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Introduction: Hemolytic disease of the fetus and newborn (HDFN) remains a serious pregnancy complication which can lead to severe fetal anemia, hydrops and perinatal death.Areas covered: This review focusses on the current prenatal management, treatment with intrauterine transfusion (IUT) and promising non-invasive treatment options for HDFN.Expert commentary: IUTs are the cornerstone in prenatal management of HDFN and have significantly improved perinatal outcome in the past decades. IUT is now a relatively safe procedure, however the risk of complications is still high when performed early in the second trimester. Non-invasive management using intravenous immunoglobulin may be a safe alternative and requires further investigation.
引用
收藏
页码：337 / 344
页数：8
相关论文
共 99 条
[1]   REPEATED DIRECT FETAL INTRAVASCULAR HIGH-DOSE IMMUNOGLOBULIN THERAPY FOR THE TREATMENT OF RH HEMOLYTIC-DISEASE [J].
ALONSO, JG ;
DECARO, J ;
MARRERO, A ;
LAVALLE, E ;
MARTELL, M ;
CUADRO, JC .
JOURNAL OF PERINATAL MEDICINE, 1994, 22 (05) :415-419
[2]   ADVERSE EFFECT OF PLASMA-EXCHANGE ON ANTI-D PRODUCTION IN RHESUS IMMUNIZATION OWING TO REMOVAL OF INHIBITORY FACTORS [J].
BARCLAY, GR ;
GREISS, MA ;
URBANIAK, SJ .
BRITISH MEDICAL JOURNAL, 1980, 280 (6231) :1569-1571
[3]   Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion [J].
Bellone, Michael ;
Boctor, Fouad N. .
TRANSFUSION, 2014, 54 (08) :2118-2121
[4]  
BERLIN G, 1985, LANCET, V1, P1153
[5]   Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation [J].
Birchenall, Katherine A. ;
Illanes, Sebastian E. ;
Lopez, Francisco ;
Overton, Timothy ;
Liebling, Rachel ;
Soothill, Peter W. ;
Abdel-Fattah, Sherif ;
Denbow, Mark .
BLOOD TRANSFUSION, 2013, 11 (04) :548-552
[6]   Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kpb [J].
Bleile, Michelle J. ;
Rijhsinghani, Asha ;
Dwyre, Denis M. ;
Raife, Thomas J. .
TRANSFUSION AND APHERESIS SCIENCE, 2010, 43 (03) :281-283
[7]   Routine urine dipsticks not necessary at every prenatal visit [J].
Borgmeyer, Matthew ;
Ruma, Michael ;
Thorp, John .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) :S131-S131
[8]   MATERNAL ANTI-D CONCENTRATIONS AND OUTCOME IN RHESUS HEMOLYTIC-DISEASE OF THE NEWBORN [J].
BOWELL, P ;
WAINSCOAT, JS ;
PETO, TEA ;
GUNSON, HH .
BRITISH MEDICAL JOURNAL, 1982, 285 (6338) :327-329
[9]   ANTENATAL SUPPRESSION OF RH ALLOIMMUNIZATION [J].
BOWMAN, JM .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1991, 34 (02) :296-303
[10]   Obstetric uses of intravenous immunoglobulin: Successes, failures, and promises [J].
Branch, DW ;
Porter, TF ;
Paidas, MJ ;
Belfort, MA ;
Gonik, B .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (04) :S133-S138
12345678910